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the supreme court and the purposes of medicine

chiatric assessment suffices, the
Court has said, to take account
of prisoners’ “medical interests”
and civil liberties, as well as the
government’s interest in prison
safety and securing defendants’
competence to stand trial.
The Court’s deference to medical authority has drawn fire from
dissenting justices on both the
left and the right. With regard to
the treatment of prisoners, Justice
John Paul Stevens criticized the
Court for withholding procedural
safeguards, allowing psychiatrists
to conflate therapeutic and security purposes, and thereby enabling
them to medicate inmates for
“institutional convenience” under
therapeutic cover. And Justice Antonin Scalia has repeatedly insisted that the purposes of medicine
are not for the profession to decide. Scalia’s dissent in Gonzales
v. Oregon (joined by Chief Justice
John Roberts) drew a bright line
between the profession’s technical expertise and social role. The
latter, he says, is a matter of “public morality,” the province of elected officials.
Will Scalia’s view gain traction? He has already brought the

new chief justice on board, and
many expect Justice Samuel Alito
to concur with Scalia, Roberts,
and Justice Clarence Thomas on
questions of public morality, including those that implicate medicine. For some, this is a chilling
prospect, portending an era of Big
Brother intrusion into the doctor–
patient relationship. For others,
the promise is one of democratic
empowerment — the making of
moral choices by popularly chosen leaders instead of technocratic
elites.
We may soon learn whether
Scalia’s perspective will prevail.
The justices’ decision last month
to consider a congressional ban
on so-called partial-birth abortion
poses the question of medicine’s
authority in stark form. Six years
ago, the Court struck down a similar state law because it lacked an
exception for maternal medical
need. But Congress tried an end
run around this ruling, in the form
of a “finding” that such abortions
are “never medically necessary.”
Physicians who perform abortions
say otherwise. Lower courts have
deferred to their views, dismissing this “finding” as unreason-

able and concluding that the congressional ban is unconstitutional.
Proponents of the ban insist
that Congress, not the medical
profession, is entitled to deference
on the question of clinical need.
Abortion-rights advocates counter that pregnant women’s health
needs are for them and their doctors to determine. Central to the
latter claim is the premise that
the medical judgment to which a
woman is entitled encompasses
the moral dimensions of the decision to abort. Should the former
view prevail, public authority over
medicine’s morality and purposes
will greatly expand. The justices
would do well to weigh the consequences for caregivers’ ability to
address patients’ varying needs.
Dr. Bloche is professor of law at Georgetown University and a visiting fellow at the
Brookings Institution, both in Washington,
D.C., and adjunct professor at Bloomberg
School of Public Health, Johns Hopkins
University, Baltimore.
1. Bloche MG. Medical ethics in the courts.
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Ethical dimensions of health policy. New
York: Oxford University Press, 2002:133-56.
2. Henderson JA Jr, Siciliano JA. Universal
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custom in determining medical malpractice.
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A

Pakistani tailor, the sole
breadwinner for a family of
eight, had received diagnoses of
type 2 diabetes and hypertension
at 31 years of age. For the next 15
years, although he felt well and
visited his primary care practitioner
twice a year, his conditions were
poorly controlled. When he was
46, he began to notice fatigue and
loss of appetite. After several weeks
of the gradual progression of these
symptoms, the man sought med-

ical attention and was found to
have a serum creatinine concentration of 5.2 mg per deciliter
(460 μmol per liter), a blood urea
nitrogen concentration of 87 mg
per deciliter (31 mmol per liter),
an estimated glomerular filtration
rate (GFR) of 10 ml per minute
per 1.73 m2 of body-surface area,
urinary albumin excretion of 1.5 g
per day, and mildly shrunken
kidneys. Twice-a-week sessions of
hemodialysis were initiated, but
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the patient had to take out a loan
to pay for them and soon was unable to afford to continue treatment. He has been lost to followup ever since.
Given pressing medical concerns such as infectious diseases
and malnutrition faced by developing countries, why should we
even talk about chronic kidney
disease in such places? The fact
is that many developing countries
are facing a silent epidemic of
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chronic kidney disease — one
facet of the health transition associated with industrialization.
Moreover, by virtue of its progression to kidney failure and its association with accelerated cardiovascular disease, chronic kidney
disease has profound effects on
morbidity, mortality, and health
care costs, as well as important
social implications.
Representative estimates of the
burden of chronic kidney disease
(defined as a decrease in the GFR
to less than 60 ml per minute per
1.73 m2 — half the normal rate
— or the presence of albuminuria for three or more consecutive
months) in most developing countries are lacking. However, data
from community-based studies in
Pakistan reveal an alarmingly high
burden. Approximately 15 to 20
percent of persons 40 years of
age or older have a reduced estimated GFR.1 Although GFR estimation equations have not been
validated in Asian populations,
such a burden is consistent with
the high prevalence of diabetes
and hypertension, the two main
risk factors for chronic kidney disease. The prevalence of diabetes in
countries of the Indian subconti-

nent (about 20 percent among persons 40 years of age or older) is
two to three times that reported
in Western countries and is projected to triple over the next two
decades. Evidence indicates that
chronic kidney disease develops in
about a third of patients with diabetes. The burden of hypertension is even higher — affecting
about one third of Pakistanis 45
years of age or older, according to
the 1990–1994 National Health
Survey of Pakistan.
These troubling rates are fueled in part by diets high in partially hydrogenated vegetable oil
and low in fresh produce, as well
as by increases in sedentary lifestyles in low-income communities,
where children spend an average
of four to six hours per day watching television. Moreover, Pakistani
children have higher blood-pressure levels, adjusted for body-mass
index, than white children in the
United States2 — and childhood
levels have been shown elsewhere
to predict levels in adulthood.
Moreover, populations in which
low birth weight and malnutrition
are common may be predisposed
to chronic diseases associated with
weight gain.3

A Patient with Kidney Failure Undergoing Hemodialysis at the Aga Khan University
Hospital, Karachi, Pakistan.
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Despite these predisposing conditions, screening for and early detection of chronic kidney disease,
particularly in high-risk patients
with hypertension and diabetes,
remain grossly inadequate. In part,
this failure may be attributed to
the fact that the health care systems in developing countries are
geared toward providing shortterm, symptomatic treatment. But
perhaps an even greater problem
is that these high-risk patients
remain largely unidentified. Although the average Pakistani adult
visits a primary care physician four
to five times each year, 64 percent
of adults have never had their
blood pressure measured, and 70
percent of patients with hypertension and 50 percent of patients
with diabetes are unaware of their
condition.4 Compounding the
problem of underdetection are
gaps in the knowledge of some
Pakistani physicians about the
management of hypertension and
diabetes, which lead to undertreatment and a lack of preventive
measures against chronic kidney
disease.
Against this backdrop of poor
medical practices, patients with
kidney failure are faced with the
high cost of renal-replacement
therapy. On the Indian subcontinent, where the per capita annual
income (calculated in U.S. dollars)
is about $400, the cost of dialysis is about $4,000 per year. Kidney transplantation costs about
$5,000, and post-transplantation
medications cost $2,000 annually.
Thus, treating kidney failure is an
unaffordable proposition for public health systems that receive 0.8
to 4 percent of the gross national
product (as compared with 10 to
15 percent in developed countries).
These hard facts, coupled with
the general lack of third-party
health insurance, mean that less
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than 10 percent of patients with
kidney failure receive any kind
of renal-replacement therapy. Although the number of hemodialysis centers is increasing in many
regions of Pakistan, most patients
who begin to receive dialysis die
or stop treatment within the first
three months because of cost constraints. Kidney transplantation is
the cheaper option, but only about
5 percent of patients with kidney
failure receive a transplant. The
shortage of donors is a universal
problem, and paid organ donation
accounts for 70 percent of all
transplantations in Pakistan.
Clearly, programs to prevent
chronic kidney disease and to
treat it in the earliest stages must
be designed and integrated into
the existing health care infrastructure. The World Health Organization’s Innovative Care for Chronic Conditions Framework provides
a model for redesigning health
care systems in accordance with
local resources. The framework
emphasizes a well-defined care
plan, self-care, scheduled followup appointments, monitoring of
outcomes, adherence, and stepwise treatment protocols delivered
mainly by primary care practitioners. However, increased referrals from such programs, even if
limited to patients with advanced
disease, may place excessive de-

mands on existing nephrology
services. At present, there are only
about 80 formally trained nephrologists in Pakistan for a population of about 160 million (the
United States has more than 5000
nephrologists for a population of
about 300 million). Capacity-building efforts are therefore needed to
train physicians in this specialty.
Until the public health services
in Pakistan are developed further,
private primary care practitioners
will continue to be the frontline
caregivers in Pakistan. These physicians should be required —
perhaps even as a prerequisite for
the renewal of licensure — to
participate in continuing medical
education programs regarding the
management of hypertension, diabetes, and chronic kidney disease.
Ideally, developing countries
would have access to ample resources to set up large-scale, integrated programs for the prevention and treatment of chronic
diseases, as well as dialysis and
transplantation units for patients
with kidney failure. But in reality,
such resources are unlikely to be
found. Low-income countries must
therefore shift their emphasis from
renal-replacement therapy to more
cost-effective preventive services,
recognizing that questions of social justice and equity will inevitably arise. Since Pakistan’s

resources are currently being directed toward the rehabilitation
of survivors of October’s earthquake, it is unlikely that more resources will be allocated for the
treatment or prevention of chronic kidney disease anytime soon.
International agencies must therefore recognize that without urgent
attention to the problem, the adverse consequences of hypertension, diabetes, and chronic kidney
disease will bring untold misery
to the next generation of inhabitants of the Indian subcontinent
— who represent one sixth of the
world’s population.
Dr. Jafar is the head of the section of nephrology, director of the clinical epidemiology unit, and an associate professor of
medicine and community health sciences
at Aga Khan University, Karachi, Pakistan,
and an adjunct faculty member at Tufts–
New England Medical Center, Boston.
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T

he attention being paid globally to chronic kidney disease
is attributable to five factors: the
rapid increase in its prevalence,
the enormous cost of treatment,
recent data indicating that overt
disease is the tip of an iceberg of
covert disease, an appreciation of
its major role in increasing the risk

of cardiovascular disease, and the
discovery of effective measures to
prevent its progression. These factors render chronic kidney disease
an important focus of health care
planning even in the developed
world, but the problems they delineate in the developing world are far
more challenging. Some 85 per-
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cent of the world’s population live
in low-income or middle-income
countries, where the clinical, epidemiologic, and socioeconomic effects of the disease are expected to
be the greatest.
Data from the United States
suggest that for every patient with
end-stage renal disease (ESRD),
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